[Advances in Experimental Medicine and Biology] Progress in Basic and Clinical Immunology Volume 495 || Exosomes in cancer immunotherapy: preclinical data
✍ Scribed by Mackiewicz, Andrzej; Kurpisz, Maciej; Żeromski, Jan
- Book ID
- 120557909
- Publisher
- Springer US
- Year
- 2001
- Tongue
- English
- Weight
- 616 KB
- Edition
- 1
- Category
- Article
- ISBN
- 1461506859
No coin nor oath required. For personal study only.
✦ Synopsis
Progress in Basic and Clinical Immunology is a result of the 14th European Immunology Meeting - EFIS 2000, held in Poznan, Poland, on 23-27 September 2000. EFIS 2000 gathered over 1400 immunologists from all over the world. It was an exceptionally memorable meeting for a number of reasons: 1) it was held in the last year of the century and the millennium, thus provoking conclusions of past achievements of immunology and projections for the future; 2) it was held in Poland, a country that is a symbol of struggle for freedom for a large number of scientists originating from the `Eastern Bloc' countries; and 3) EFIS celebrated its 25th anniversary at this occasion. This comprehensive volume contains 62 chapters grouped into 11 sections: T-cells, Immune Receptors, Antigen Presentation/Dendritic Cells, Cytokines, Immunodeficiencies, Autoimmunity, Allergy/Inflammation, Immunotherapy, Vaccines, Tumor Immunology, and Cancer Immunotherapy.
📜 SIMILAR VOLUMES
Treatment Of Glioma Is Currently One Of The Most Challenging Problems In Oncology, As Well As In Neurosurgery. Despite Major Advances In Our Understanding Of The Pathomechanism, Diagnosis By Imaging And The Availability Of Powerful Therapeutic Tools, The Life Expectancy Of Patients With Glioblastoma
Caveolae are 50-100 nm flask-shaped invaginations of the plasma membrane that are primarily composed of cholesterol and sphingolipids. Using modern electron microscopy techniques, caveolae can be observed as omega-shaped invaginations of the plasma membrane, fully-invaginated caveolae, grape-like cl
Programmed cell death (PCD) plays pivotal roles in tumor progression, cancer therapeutics and resistance of tumor cells to therapy. This book examines the mechanisms involved in mediating and regulating PCD in cancer. It also provides a detailed indication of the utility of PCD in cancer therapy. Th